Athyrium Opportunities 2020 LP 13D and 13G filings for Biora Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-02 8:43 pm Purchase | 2024-03-31 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 1,930,628 49.900% | 309,176 (+19.07%) | Filing |
| 2023-12-20 4:35 pm Purchase | 2023-12-18 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 1,621,453 49.900% | 386,569 (+31.30%) | Filing |
| 2023-09-19 4:15 pm Purchase | 2023-09-18 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 1,234,884 49.900% | 867,926 (+236.52%) | Filing |
| 2023-03-13 4:18 pm Purchase | 2023-03-10 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 366,958 32.700% | 82,414 (+28.96%) | Filing |
| 2023-01-12 4:46 pm Sale | 2023-01-03 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 284,544 27.800% | -177,555,628 (-99.84%) | Filing |
| 2022-11-18 4:30 pm Purchase | 2022-11-09 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 177,840,173 28.400% | 10,022,310 (+5.97%) | Filing |
| 2021-11-26 4:45 pm Purchase | 2021-11-24 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 167,817,863 31.100% | 167,817,863 (New Position) | Filing |